Related by context. All words. (Click for frequent words.) 82 Activator CK # 74 Oral Fingolimod 72 Selective Cardiac Myosin Activator 72 Clinical Trial Results 71 Sangamo BioSciences Announces 71 Late Breaker 71 Antitumor Activity 71 Poster Discussion 70 Anti Tumor Activity 70 Pooled Analysis 70 Dose Escalation 70 Phase 2a Trial 69 Randomized Double Blind Placebo 69 Preclinical Data 69 Study Evaluating 69 Clinical Trials Update 69 Relapsing Multiple Sclerosis 69 Poster Presentations 69 Poster Presentation 69 Double Blind Placebo 69 Hsp# Inhibitor 69 Renal Function 69 Clinical Trial Data 69 Preclinical Study 69 Controlled Trial 69 Abstract Accepted 69 Nephrol Dial Transplant 68 Anti Tumor 68 Abstract Number 68 Brain Metastases 68 Prolongs Survival 68 Proc Am Soc 68 Arch Pediatr Adolesc Med 68 Orthop Surg 68 Novel Oral 68 See CLINICAL PHARMACOLOGY 68 FASEB J. 68 Randomized Double Blind 68 Randomized Double blind 68 Vaccine Adjuvant 68 Treatment Naïve 67 J Am Soc 67 Phase 2a Clinical Trial 67 II Clinical Trial 67 Phase 2b Clinical Trial 67 Metastatic Melanoma 67 Predict Risk 67 Combination REOLYSIN R 67 Clinical Outcome 67 Immune Responses 67 Meets Primary Endpoint 67 Ann Rheum Dis 67 Mg Usa 67 Randomized Phase II 67 Recurrent Breast Cancer 67 Dendritic Cells 67 #nd EORTC NCI 67 Decitabine 67 LENALIDOMIDE 67 Therapeutics TCT scientific 67 Diabetic Nephropathy 67 Advanced Renal Cell 67 Adjuvant Chemotherapy 67 Unfractionated Heparin 67 Safety Tolerability 67 Critically Ill Patients 67 Novel Inhibitor 67 Kinase Inhibitor 67 Nicotine Vaccine 67 Improve Survival 67 Hemodialysis Patients 66 Oral Presentations 66 AACR IASLC Joint 66 Ann Oncol 66 Completes Patient Enrollment 66 Adjunctive Therapy 66 Int J Obes Relat 66 Drug Candidate 66 Pulmonary Vein Isolation 66 entitled Synergistic 66 Arch Neurol 66 Orally Active 66 Endocrinol Metab 66 Phase 2b Trial 66 Mylan Receives Approval 66 J Am Coll 66 Anticancer Drugs 66 Patients Treated With 66 Chronic Hepatitis C 66 JAK2 Inhibitor 66 Neoadjuvant Chemotherapy 66 Single Dose 66 First Patient Enrolled 66 Heart Failure Patients 66 Preclinical Efficacy 66 J Am Acad 66 Castration Resistant Prostate Cancer 66 Presents Preclinical Data 66 Tumor Response 66 Postmenopausal Women 66 Hormone Refractory Prostate Cancer 66 Nephrol 66 Immunomedics Announces 66 SABCS 66 Refractory Angina 66 J Allergy Clin 66 Antiviral Activity 66 Drug Combo 66 Patients Undergoing 66 Left Ventricular 66 Effectively Treats 66 Nuvelo Announces 66 Gene Variation 65 Skin Lesions 65 Kidney Transplant Patients 65 Attenuates 65 Previously Treated 65 novel VDA molecule 65 Levels Linked 65 Treating Chronic 65 Placebo Controlled Trial 65 Slow Progression 65 Phase III Clinical Trial 65 Shows Promise Against 65 Suppl. 65 Severe Sepsis 65 Improves Survival 65 Sapacitabine 65 By JENNIFER LEARN 65 Randomized Controlled Trials 65 Investigational Compound 65 Demonstrate Significant 65 Demonstrated Significant 65 Meta Analysis 65 Recombinant Human 65 Tezampanel 65 Announcement acc 65 IN PATIENTS WITH 65 Child Adolesc Psychiatry 65 J Shoulder Elbow 65 Relapsed Multiple Myeloma 65 Cholesterol Lowering Drug 65 Fast Skeletal Troponin 65 Demonstrates Significant 65 Initiates Enrollment 65 J Antimicrob Chemother 65 Inflammatory Markers 65 Randomized Phase 65 Novel Antibiotic 65 Novel Small Molecule 65 Antiviral Therapy 65 phenyl salicylate methylene blue 65 Epilepsy Drug 65 Metastatic Renal Cell Carcinoma 65 Cardiac Function 65 CYP#A# CYP#D# 65 Desvenlafaxine Succinate 65 Fungal Infections 65 Pre Cancerous 65 Patients Suffering 65 Phase IIb Clinical Trial 65 Shows Promising 65 vapreotide acetate 65 Ranolazine 65 Randomized Study 65 Topline Results 65 Controlled Study 65 Naive Patients 65 Am J Clin 65 Receives Orphan Drug Designation 65 Melanoma Skin Cancers 65 Transdermal Patch 65 Randomized Clinical Trial 65 Breaking Clinical Trials 64 Venous Thrombosis 64 Prospective Randomized 64 PROSTASCINT R 64 Orthostatic Hypotension 64 Vitro Activity 64 Improves Outcomes 64 Pivotal Phase III 64 Well Tolerated 64 Clinical Efficacy 64 Carotid Stenting 64 AP Photo DCMC# 64 Gene Linked 64 Free Full Text 64 Granted Orphan Drug 64 Treatment Regimen 64 Adenoviral 64 Hyperlipidemia 64 Safinamide 64 Cardiotoxicity 64 Kidney Function 64 Hematological Malignancies 64 Elderly Patients 64 Novel Method 64 Cell Physiol 64 J Clin Endocrinol Metab 64 Survival Benefit 64 FDA APPROVES 64 6 pgs #k 64 Breast Cancer Recurrence 64 Lymph Nodes 64 Synta Announces 64 Mg Uk 64 Stent Restenosis 64 WRX STi +# mins 64 Unternehmen der EquityStory AG 64 Myelodysplastic Syndromes 64 PRAECIS PHARMACEUTICALS INCORPORATED 64 Treat Anemia 64 Hypercholesterolemia 64 Submits NDA 64 Pharmacokinetic Study 64 Vaccine Adjuvants 64 Phase 2b Study 64 Dose Ranging Study 64 Sleep Disturbances 64 Randomized Trials 64 http:/www.ncbi.nlm.nih.gov/pubmed/# 64 AASLD Meeting 64 Randomized Clinical Trials 64 Colorectal Cancer Patients 64 Am J Epidemiol 64 Oral Presentation 64 Environ Health Perspect 64 Treatment Experienced 64 Lowers Risk 64 Multicenter Phase 64 #rd Annual CTRC 64 HCV Protease Inhibitor 64 Advanced Solid Tumors 64 Serious Infections 64 WHO TOOK 64 J Pediatr 64 doi #.#/fj.#-# 64 UGNE 64 HCV Genotype 64 Telik Announces 64 Bare Metal Stents 64 #:#-# Abstract Free [009] 64 TO AVOID PREGNANCY WHILE 64 CYT# potent vascular disrupting 64 J.P. Morgan Healthcare 64 Demonstrates Positive 64 Tissue Engineered 64 Appears Safe 64 J Natl Cancer Inst 64 Beneficial Effects 64 Adjuvant Treatment 64 AACR San Antonio 64 Knee Osteoarthritis 64 Breast Ultrasound 64 Lipid Levels 64 ASCO GI 64 Improved Survival 64 Investigational Agent 64 pralatrexate injection folate analogue 63 Myocardial Perfusion Imaging 63 Bone Metastases 63 RNAi Therapeutic 63 Int J Epidemiol 63 Am J Gastroenterol 63 Novel Approaches 63 Initiate Phase 63 AACR #st Annual Meeting 63 Pulmonary Arterial Hypertension 63 ST Segment Elevation 63 Seasonal Allergic Rhinitis 63 Proves Effective 63 Phase IIb Trial 63 Curr Opin 63 Biological Therapy 63 에 을 63 Autologous Stem Cell Transplantation 63 Inhaled Corticosteroids 63 Stent Thrombosis 63 Phase Ib Clinical Trial 63 AABB Annual Meeting 63 Advanced Melanoma 63 Statin Therapy 63 Cochrane Database Syst Rev. 63 USpella 63 Fecal Incontinence 63 Therapeutic Targets 63 Crit Care Med 63 Prognostic Significance 63 Eur J 63 Announces Poster Presentations 63 MIND CTI LTD 63 Clinical Trial Evaluating 63 Uterine Fibroid Embolization 63 Patient Enrollment 63 ORAL Sync 63 Long Term Outcomes 63 Prospective Multicenter 63 Outpatient Setting 63 Subgroup Analysis 63 Hospitalized Patients 63 Am J Obstet 63 Clinical Evaluation 63 Inflammatory Arthritis 63 Total Knee Arthroplasty 63 Hormone Receptor Positive 63 Drug Shows Promise 63 Natalizumab 63 Podium Presentation 63 FBOVESPA 63 Patients Receiving 63 Tyrosine Kinase Inhibitor 63 Therapeutic Efficacy 63 Platelet Inhibition 63 SYN# 63 intravesical infusion therapy 63 Renal Tumors 63 lexidronam injection 63 benzoic acid hyoscyamine sulfate 63 R lenalidomide 63 SA FC# 63 Initiates Clinical Trial 63 Bare Metal Stent 63 Vertebral Fractures 63 Gentium Announces 63 Investigational Drug 63 Plaque Psoriasis 63 Protease Inhibitor 63 Pivotal Clinical Trial 63 Confirmatory Phase 63 #:#-# Abstract Free [006] 63 Complicated Skin 63 Renal Impairment 63 Kidney Int 63 ANN INTERN MED 63 Dapagliflozin 63 Hematological Cancers 63 GBP #,#,#.# 63 Hedgehog Pathway 63 Slows Progression 63 Node Positive 63 Contrast Agents 63 PDUFA Date 63 Brentuximab Vedotin SGN 63 Respiratory Distress 63 ASCO GU 63 Receives Orphan Drug 63 Nebulized 63 NDA Submission 63 Gene Mutations 63 Endocrinol 63 J Clin Oncol 63 Thromb Haemost 63 ASCO Gastrointestinal Cancers Symposium 63 Presents Positive 63 Teva Provides Update 63 transthyretin TTR mediated amyloidosis 63 Relapsed Refractory 63 Acute Ischemic Stroke 63 Treated Patients 63 brand ciclesonide HFA 63 #:#-# Abstract Free [004] 63 migraines neurorehabilitation 63 #:#-# Abstract Free [005] 63 PEGylated anti 63 Expanded Indication 63 Shows Efficacy 63 STRIDE PD 63 Eur J Cancer 63 Comorbidities 63 Statin Drugs 63 Study Shows Benefits 63 Newly Diagnosed Patients 63 #th Annual Interscience 62 Double Blind Randomized 62 Demonstrates Sustained 62 Localized Prostate Cancer 62 Completes Enrollment 62 Statistically Significant 62 J Cataract Refract 62 Randomized Phase III 62 Patient Enrolment 62 TNF Tumor Necrosis Factor 62 Small Molecule 62 IND Filing 62 Reports Preclinical Data 62 Nat Genet 62 Multiple Myeloma Patients 62 Overactive Bladder 62 Files IND 62 HDAC Inhibitors 62 Drug Eluting Coronary Stent 62 Prospective Randomized Trial 62 Minimally Invasive Treatment 62 paris@afxnews.com afp 62 Dose Ranging 62 AACR Meeting 62 Microalbuminuria 62 Therapy Improves 62 Gastric Cancer 62 Combination Treatment 62 Neuroendocrine Tumors 62 Cognitive Impairment 62 Chronic Lymphocytic Leukemia 62 Cochrane Database Syst Rev 62 cows boners #-# 62 Systemic Sclerosis 62 Blood Pressure Drugs 62 #:#-# Abstract Free [008] 62 Antiplatelet 62 Biologic Therapy 62 Soft Tissue Sarcoma 62 Treatment Reduces 62 Lowering Blood Pressure 62 Rheumatoid Arthritis Patients 62 Microwave Ablation System 62 SIPC CRD # 62 Diabetic Neuropathy 62 Placebo Controlled Study 62 Significantly Improves 62 Potassium Chloride Sodium Ascorbate 62 MRI Patient Monitoring 62 J Foot Ankle 62 Phase IIa Clinical Trial 62 IND Application 62 fosbretabulin 62 Surgical Mesh 62 Hazardous Drugs 62 Ventricular Arrhythmias 62 Abdominal Fat 62 ECCMID 62 Thyroid Hormone 62 Long Term Efficacy 62 Annual ICAAC 62 Treatment Shows Promise 62 Eur Respir J 62 Abstract Full Text 62 Chronic Hepatitis B 62 Am J Pathol 62 #:#-# Abstract Free [010] 62 DIURIL R 62 Cardiol 62 nd Annual Meeting 62 는 의 62 Liver Failure 62 Systemic Delivery 62 AACR symposium 62 ICAAC IDSA 62 hyperphenylalaninemia HPA due 62 abstr 62 ERRED BY 62 Inhaled Nitric Oxide 62 FDA Approves Drug 62 IS WHERE IS 62 Parathyroid Hormone 62 Presents Preclinical 62 Vildagliptin 62 NEWS RELEASE THE COMPANY 62 Osteoarthritis Patients 62 Clin J 62 Demonstrates Efficacy 62 Reduces Mortality 62 Disease Modifying 62 Pharmacokinetics PK 62 Lung Cancer Trial 62 Adjuvant Therapy 62 Premenopausal Women 62 Pregnancy Linked 62 Newly Diagnosed Multiple Myeloma 62 HDAC Inhibitor 62 Acute Decompensated Heart Failure 62 MicroMacro TM Multi 62 NASDAQ CYTK announced 62 Often Misdiagnosed 62 Anticancer Drug 62 Neurol 62 Cilostazol 62 EORTC NCI 62 INCB# [003] 62 J.P. Morgan SMid Cap 62 CompilerParameters options CodeCompileUnit 62 DOES NOT CONSTITUTE AN 62 FDA Approvals 62 Surgical Treatment 62 REMINDER ORLive Presents 62 Acute Heart Failure 62 Migraine Drug 62 Biomarker Study 62 By KushalSharma TennisEarth.com 62 octreotide acetate 62 Protein Expression 62 Eyvind Brynildsen Mitsubishi Lancer 62 HOOK UP WITH 62 PT S# 62 Myeloma Patients 62 Lymphocytic 62 Contrast Agent 62 Androgen Receptor 62 Ultrasound Guided 62 Epoetin Alfa 62 cows boners #-#.# 62 Percutaneous Tibial Nerve Stimulation 62 Viral Infections 62 Vaccine Protects Against 62 Oral Calcitonin 62 Suppl 62 FORECASTS PROJECTIONS EXPECTATIONS OR 62 Heart Failure Therapies 62 Breast Tumors 62 Malignant Lymphoma 62 vaggm @ gnnewspaper.com 62 Non Invasive Treatment 62 Catheter Associated 62 Cadillac CTS #.#L V6 62 Biol Psychiatry 62 Test Detects 62 Polymerase Inhibitor 61 Investigational Treatment 61 Initiate Clinical Trial 61 Dermatol 61 Psychiatric Services #:#-#,# 61 Aggressive Prostate Cancer 61 Romiplostim 61 Receives Fast Track 61 #-# Full Text 61 Glufosfamide 61 ASH Annual Meeting 61 memantine HCl 61 Arch Dis Child 61 Prognostic Value 61 refractory chronic lymphocytic 61 #mg #mg #mg [003] 61 NOT PACK ITEMS 61 Interferon beta 1b 61 Gets FDA Clearance 61 HER2 Positive 61 Breast Carcinoma 61 HFALLON@COMMUNITYPRESS.COM 61 Chronic HCV 61 First Patient Treated 61 Cancer Patients Treated 61 Cell Transplant 61 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 61 Premature Infants 61 #:#-# [023] 61 Hepatitis C Genotype 61 Therapeutic Approaches 61 Increased Mortality 61 Randomized Comparison 61 Is Well Tolerated 61 JAK Inhibitor 61 Aurora Kinase 61 Gastrointestinal Cancers Symposium 61 By AjayTyagi TennisEarth.com 61 lot codes T# 61 COMPANY ASSUME ANY RESPONSIBILITY 61 Chicago Multidisciplinary Symposium 61 Symptom Relief 61 口语 61 AHA Scientific Sessions 61 Pivotal Phase 61 Successfully Treated 61 Poorly Controlled 61 PAGE Staff Writer 61 Monotherapy 61 Adefovir 61 Systematic Review 61 Peer Reviewed Journal 61 #:#-# Abstract Free [003] 61 EORTC NCI AACR 61 Patients Enrolled 61 Drug Eluting 61 FDA Okays 61 Metastatic Prostate Cancer 61 treat benign prostatic 61 novel orally inhaled 61 Virus Linked 61 Mitral Valve Repair 61 sorafenib tablets 61 ROADWAYS WILL 61 PRICE GREAT DISCOUNT FREE 61 Pegylated Liposomal Doxorubicin 61 aux abonnés 61 FOLFOX6 chemotherapy regimen 61 afp cmr 61 Crit Rev 61 candidates Azedra TM 61 KARASH 61 OR THE APPLICABLE 61 Cardiovascular Prosthetic Devices 61 BY RYAN ERNST 61 Ann Intern Med 61 Tolerability 61 Clin Chem 61 interferon gamma 1b 61 By RohitSharma TennisEarth.com 61 Rotavirus Vaccine 61 Regeneron Pharma 61 Catheter Ablation 61 Tumor Cells 61 Obstet Gynecol 61 GATTEX TM 61 Minimally Invasive Procedure 61 SHALL NOT BE LIABLE 61 Venous Thromboembolism 61 Fondaparinux 61 AACR NCI EORTC 61 BNVID 61 #:#-# [007] 61 Treat Heart Failure 61 Aggressive Reduction 61 evaluating tivozanib 61 Belimumab 61 Peginterferon Alfa 2a 61 -swf file 61 Oral Solution VISICOL 61 UEGW 61 Hepatocellular Carcinoma 61 N acetylgalactosamine 6 61 PLEASE REFER TO 61 Capsules CII 61 Inflammatory Disease 61 Genes Linked 61 Psychopharmacol 61 Radiation Dose 61 Poster Session 61 Cimzia ® certolizumab pegol 61 Zorbtive TM 61 Patient Outcomes 61 ART INSTRUCTOR 61 Br J Cancer 61 MUST CLICK ON 61 Acute Myocardial Infarction 61 Benign Prostatic Hyperplasia 61 Bazedoxifene 61 SHIPPING IS OUTSOURCED 61 Genitourinary Cancers Symposium 61 考试 61 CCNMATTHEWS 61 Neuroprotective Effects 61 FOR ANY INVESTMENT OR 61 Arch Surg 61 Allogeneic 61 Phase III Trial 61 number NCT# ClinicalTrials.gov 61 INSPIRE Trial Phase III 61 Protein Synthesis 61 Cancer Incidence Mortality 61 Rolled Glass 61 Obes Res 61 Carbidopa Levodopa 61 Newly Diagnosed Breast Cancer 61 Targeted Therapies 61 mGluR5 negative 61 CHANGES IN PROJECT PARAMETERS 61 Stent Placement 61 FOLFOX6 61 Metered Dose Inhaler Devices 61 Jari Ketomaa Subaru Impreza 61 #:#-# [020] 61 BYETTA ® 61 Inc. Nasdaq IMGN 61 SKEMME@ENQUIRER.COM 61 POL PRO 61 Aggressive Drug Evaluation 61 CELGENE 61 Image Guided 61 Multicenter Study 61 Initiates Phase III 61 Methylnaltrexone 61 BY REPRESENTATIVES OF 61 Improves Accuracy 61 abacavir sulfate lamivudine 61 Genes Identified 61 Intracerebral Hemorrhage 61 injection USP ENDOMETRIN 61 Genetic Defect 61 Medication Adherence 61 Mycophenolate Mofetil 61 WRX +# mins 61 balsalazide disodium Capsules 61 bone marrow reticulin deposition 61 Arch Intern Med 61 Study Showed 60 Pivotal Trial 60 DETECTS POSSIBLE BULLISH HARAMI 60 Bucindolol 60 reduce serum phosphate 60 CSCMP Annual Conference 60 DOI #.#/hep.# 60 EMRG VIO 60 Invasive Breast Cancer 60 Functional Outcomes 60 INDIVIDUALLY AND 60 FROM NOON 60 Patients Treated 60 pioglitazone HCl 60 DETECTS POSSIBLE BEARISH INSIDE 60 Clin Infect Dis 60 Tipranavir 60 Upcoming Investor Events 60 Acta Paediatr 60 JAPAN SOCIETY 60 includes Dideco CarboMedics 60 Hedgehog Pathway Inhibitor 60 PRN FDA Approves 60 Molecular Diagnostic Test 60 NASDAQ AVNR 60 Bivalirudin 60 Oral Session 60 Immunosuppression 60 AIXTRON AG FSE AIX 60 Genetic Mutations 60 ST Elevation Myocardial 60 By BRENDA ALLUMS 60 GNSZ 60 DG# compounds targeting 60 By ALAN GREENBERG 60 Coronary Revascularization 60 Arch Dermatol 60 Radiofrequency Ablation 60 Osteoporosis Drug 60 篇 60 Serostim ® 60 ® pioglitazone HCl 60 Oral Laquinimod 60 ACCEPT CREDIT CARDS 60 J Affect Disord 60 Molecular Origins 60 #:#-# Abstract Free [007] 60 HCV NS5B polymerase 60 Successfully Treats 60 Hematology Molecular Pathology 60 Susceptibility Gene 60 Schizophrenia Treatment 60 worsening thrombocytopenia 60 Gout Drug 60 J Clin 60 Imaging Technique 60 WILL NOT BE REFUNDED 60 INFORMATION EXPRESS 60 PRNewswire FirstCall QIAGEN NV 60 MorphoSys AG FSE MOR 60 Enoxaparin 60 Am J Geriatr 60 Pivotal Study 60 Veröffentlichung einer 60 RELEASE ACCORDING TO 60 Ischemic Stroke 60 Potent Antiviral Activity 60 Personalized Immunotherapy 60 coronary stent merged 60 Evo +# mins 60 Risk Stratification 60 am Guchhait 60 PART OF ANY OTHER 60 Lupus Drug 60 ON THE FOLLOWING 60 MBRX 60 Combo Therapy 60 ACR ARHP 60 J Clin Invest 60 ® ethylene vinyl 60 #:#-# Abstract Free [001] 60 Salix Pharmaceuticals Announces 60 IS PROVIDED AS IS 60 Hematological 60 Seasonal Influenza Vaccine 60 Prostate Cancer Symposium 60 Loceryl ® 60 Canaccord Adams Hepatitis C 60 Related Disorders ICAD 60 Content Outline 60 Thrombus Aspiration 60 1mg 2mg 60 Romidepsin 60 Society CTOS 60 Sipuleucel T 60 Melphalan 60 Blocked Arteries 60 Innate Immunity 60 BIOCOM Investor Conference 60 FEEDS & 60 CEO www.squeezetrigger.com +#-#-#-# 60 Phase 2a Study 60 Nasdaq AEGR 60 Differential Diagnosis 60 Achieves Primary Endpoint 60 mainscow@economicnews.ca 60 T# T# [002] 60 Crofelemer budesonide foam 60 Anti Clotting Drug 60 Carotid Endarterectomy 60 Magnetic Nanoparticles 60 Liposomal 60 AAG geldanamycin analog 60 non nucleoside inhibitor 60 humanized interleukin 6 60 Anti CD# Antibody 60 Endometrial Cancer 60 dual endothelin receptor antagonist 60 Muscle Wasting 60 Sidoti Emerging 60 Two Investor Conferences 60 Fulvestrant 60 Testosterone Gel 60 Patient Tables Computerized 60 Metabolic Disorder 60 Aflibercept 60 #:#-#,# [003] 60 Physiology Seminar 60 Therapy Reduces 60 THE PROXY STATEMENT BECAUSE 60 CROI 60 Announces Tentative Approval 60 NOT SHIP ANY ITEMS 60 THE EXPRESSED WRITTEN CONSENT 60 Pemphigus Vulgaris 60 Prostate Biopsy 60 Confocal Microscopy 60 COLAZAL ® 60 #:#-# [031] 60 -# dBc typical 60 Relapsing Remitting Multiple Sclerosis 60 Eine bessere Art 60 Febuxostat 60 AUA Annual Meeting 60 Heterozygous Familial Hypercholesterolemia 60 Breast Tissue 60 Warfarin Coumadin 60 Receives NASDAQ 60 Guidelines Issued 60 Ziel einer europaweiten Verbreitung 60 Treating Depression 60 Clinically Significant 60 ECONOMIC EVALUATIONS AND 60 Initiated Phase 60 Stromal Cells 60 R pioglitazone HCl 60 candesartan cilexetil 60 Gynecol Oncol 60 Vaccine Immunology 60 Diabetic Foot Ulcer 60 AVAILABLE AND 60 TO YOU OR ANYONE 60 Atomoxetine 60 CAPEX REPORTED REVENUE 60 Oligonucleotides 60 CYPHER R Sirolimus Eluting 60 Ondansetron Injection USP 60 Inhalation Aerosol 60 ORLive Presents 60 RESPONSIBLE FOR ANY DELAY 60 Acetate Rectal Suppositories 60 Maven Semantic 60 Chemotherapy ICAAC Infectious Diseases 60 orally administered inhibitor 60 Traficet EN 60 Improving Patient Safety 60 Lung Cancer Drug 60 By HOWARD WEISS 60 Phase III Trials 60 Clostridium difficile Infection 60 Generic Version 59 AACR Symposium 59 #st Annual Meeting 59 J Nerv Ment Dis 59 Vascular Grafts 59 complement inhibitor eculizumab 59 ASBMR 59 www.nejm.org 59 Laboratory pH Electrodes 59 vitreoretinal disorders 59 RCW Breast Cancer 59 JEFF FEINGOLD NEW HAMPSHIRE 59 EGFR HER2 59 Optical Coherence Tomography 59 REPORTS THIRD QUARTER 59 Telaprevir VX 59 THAT CAUSE RESULTS 59 Neurosurg 59 STATEMENT AND SHOULD UNDERSTAND 59 RECORD1 59 Prognostic Factors 59 IN ANY TRANSCRIPT 59 THE RESTAURANTS INDUSTRY 59 Deforolimus 59 R brand levalbuterol 59 IMPACT DCM 59 Ovitrelle R Serostim 59 Peripheral Arterial 59 brivanib 59 COLAZAL R 59 Advanced Prostate Cancer 59 #nd Annual Meeting 59 HER2 Positive Breast Cancer 59 Colorectal Cancers 59 Diagnostic Tests 59 #S #S [002] 59 Technological Advances 59 Kidney Transplants 59 LAYLEH 59 THAT WE WILL 59 liver resection surgeries 59 RENAL 59 Glatiramer Acetate 59 RESPONSIBILITY OF 59 Transdermal Delivery 59 Laryngeal Cancer 59 Microplasmin 59 Antibody Therapeutics 59 Services #:#-#,# Abstract 59 By KarenWalker TennisEarth.com 59 Tolvaptan 59 ASCO Breast Cancer 59 Metformin HCl 59 OF SOURCES FROM WHICH 59 Clinical Practice Guideline 59 PROCTOCORT ® Suppository Hydrocortisone 59 Embolic Protection 59 CHUCK LIDDY cliddy@newsobserver.com CHUCK 59 EORTC NCI AACR Symposium 59 HCl PEPCID ® famotidine 59 CCX# B 59 INC. DOES NOT 59 Aortic Stenosis 59 Selective Inhibitor 59 FOLOTYN ® 59 Arthritis Drug 59 #th Interscience Conference 59 RNAi Therapeutics 59 DATE HEREOF AND 59 ® famotidine 59 Bortezomib 59 OF VARIOUS PROJECT 59 Mortality Risk 59 Subtypes 59 Marcus Gronholm BP 59 #.#/mo 1yr 59 TM Pharmacy Pumps 59 Brain Wiring 59 Fixed Dose 59 CD# [004] 59 www.telik.com 59 ADVISED THAT 59 CombAT 59 metastatic castration resistant 59 Oral Suspension Oral Suspension 59 Cardiovascular Outcomes 59 DOES SEEKING ALPHA ASSUME 59 Gene Silencing 59 HuCAL PLATINUM ® CysDisplay 59 Female Urology 59 carbamazepine phenobarbital phenytoin rifampin 59 THE HOTELS RESORTS 59 Plasmid DNA 59 FDA Approvable Letter 59 Molecular Cancer 59 SELLERS ABANDONING SHARES OF 59 Training Effectiveness 59 Breaking Clinical Trial 59 Ancrod 59 INTERESTS AND CERTAIN 59 AAEP Convention 59 Initiates Clinical Trials 59 metformin HCl 59 Chemoradiation 59 Chronic Lymphocytic Leukemia CLL 59 DECISIONS OF 59 Denufosol 59 Developmental Therapeutics Immunotherapy 59 EFNS 59 Rotavirus Vaccines 59 Heart Rate Variability 59 www.durect.com 59 Expedited Review 59 Pioglitazone 59 Chronic Heart Failure 59 ECONOMIC CONDITIONS 59 Stent Implantation 59 aaron.gray block @ thomsonreuters.com 59 liposome injection 59 OFFICE SAYS 59 #:#-#,# CrossRef Medline [002] 59 DO NOT MEET CUSTOMERS 59 Active Ulcerative Colitis 59 azilsartan medoxomil 59 Dave van Ginhoven 59 Milestone Payment 59 Heart Transplant Recipients 59 article #.#/NEJMoa# 59 R roscovitine 59 Upcoming Conferences 59 NEEDS WHICH MAY CAUSE 59 INTERPRETING REPORTING OR DELIVERING 59 Neuro Oncology SNO 59 Lenalidomide 59 CLAIMS AND 59 Bacterial Pathogens 59 Female Stress Urinary